Bausch Health Cos Total Long-Term Assets 2010-2024 | BHC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch Health Cos total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bausch Health Cos total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$11.2B
BridgeBio Pharma (BBIO)	$6.9B
Supernus Pharmaceuticals (SUPN)	$1.9B
Amphastar Pharmaceuticals (AMPH)	$1.5B
Personalis (PSNL)	$412M
Taysha Gene Therapies (TSHA)	$336M
Assembly Biosciences (ASMB)	$81M
Sol-Gel Technologies (SLGL)	$16M
Evoke Pharma (EVOK)	$8M
Teligent (TLGT)	$0M